Skip to main content
. Author manuscript; available in PMC: 2021 Jul 22.
Published in final edited form as: Cancer Drug Resist. 2021 May 30;4:634–645. doi: 10.20517/cdr.2021.27

Figure 1.

Figure 1.

(A) The ubiquitin-mediated protein degradation pathway. Proteins, polyubiquitinated by an enzyme complex containing a ubiquitin-activating enzyme (E1), a ubiquitin-conjugating enzyme (E2), and a ubiquitin-protein ligase (E3), are recognized and degraded by the 26S proteasome. (B) Two main (or standard) 20S proteasome subtypes present in mammalian cells: the constitutive proteasome (cP) and immunoproteasome (iP).